ICD-10 Code B38.3 | Cutaneous coccidioidomycosis Symptoms, Diagnosis, Billing

Cutaneous coccidioidomycosis is a fungal infection caused by Coccidioides species, primarily affecting the skin. It is clinically significant due to its potential to cause severe skin lesions and systemic complications. Accurate coding with ICD-10 Code B38.3 facilitates precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.

What is ICD-10 Code B38.3 for Cutaneous coccidioidomycosis?

ICD-10 Code B38.3 represents Cutaneous coccidioidomycosis, a skin manifestation of coccidioidomycosis, which is caused by the Coccidioides fungus. This code should be used when documenting cases of skin lesions resulting from this infection, ensuring accurate billing and clinical documentation for effective patient management.

ICD-10 Code B38.3 – Clinical Definition and Explanation of Cutaneous coccidioidomycosis

Cutaneous coccidioidomycosis is caused by the Coccidioides immitis or Coccidioides posadasii fungi, typically acquired through inhalation of spores. The condition can progress to skin lesions, requiring prompt medical attention to prevent complications. Early diagnosis and treatment are crucial for effective management.

Key Clinical Features:

• Erythematous papules or nodules on the skin
• Potential for ulceration and secondary infections
• History of exposure to endemic areas (e.g., Southwestern U.S.)
• Possible systemic symptoms such as fever and malaise

ICD-10 Code B38.3 for Cutaneous coccidioidomycosis – SOAP Notes & Clinical Use

ICD-10 Code B38.3 is utilized in SOAP notes to document the presence of cutaneous coccidioidomycosis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B38.3 for Cutaneous coccidioidomycosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B38.3 connects subjective reports of skin lesions and objective clinical findings to a formal diagnosis of cutaneous coccidioidomycosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B38.3 – Cutaneous coccidioidomycosis

Prompt treatment of cutaneous coccidioidomycosis is essential to prevent complications and promote healing. Hospitalization may be necessary for severe cases.

Antibiotic Therapy:

• Fluconazole: 400 mg daily for 3-6 months
• Itraconazole: 200 mg daily for 3-6 months
• Voriconazole: 200 mg twice daily for 3-6 months

Supportive Care:

• Topical antifungal creams for localized lesions
• Pain management with analgesics
• Wound care to prevent secondary infections

Infection Control:

• Educate patients on avoiding exposure to dust in endemic areas
• Implement precautions for immunocompromised patients
• Monitor for signs of systemic spread during outbreaks

How to Document Symptoms of Cutaneous coccidioidomycosis (ICD-10 B38.3) in SOAP Notes

Subjective:

• Patient reports new skin lesions with itching and redness.
• History of travel to endemic areas within the last month.
• Complaints of fever and malaise accompanying skin symptoms.

Objective:

• Erythematous papules noted on examination.
• No signs of systemic infection (e.g., stable vital signs).
• Skin lesions measure 1-3 cm in diameter with some ulceration.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Cutaneous coccidioidomycosis (ICD-10 Code B38.3)

Assessment:

• Diagnosis: Cutaneous coccidioidomycosis, moderate severity.
• ICD-10 Code: B38.3.
• Contributing factors: Recent travel to endemic region.

Plan:

• Initiate fluconazole 400 mg daily for 3 months.
• Educate patient on skin care and signs of infection.
• Schedule follow-up in 4 weeks to assess treatment response.

Treatment & Plan Section for ICD-10 Code B38.3 – Cutaneous coccidioidomycosis

• First-line treatment includes fluconazole or itraconazole.
• Non-pharmacologic strategies include proper wound care and hygiene.
• Monitor for treatment efficacy through follow-up visits.
• Educate patients on avoiding exposure to Coccidioides spores.

Using ICD-10 Code B38.3 for Cutaneous coccidioidomycosis in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings.
• Document symptoms clearly under Subjective (S) and Objective (O) sections.
• Ensure treatment plans align with clinical guidelines for justified billing.
• Include relevant CPT codes for services rendered alongside B38.3.

Related ICD-10 Codes Often Used with Cutaneous coccidioidomycosis

• B38.0 – Coccidioidomycosis, unspecified
• B38.1 – Pulmonary coccidioidomycosis
• B38.2 – Coccidioidomycosis with other manifestations

ICD-10 Code B38.3 in Medical Billing and Insurance for Cutaneous coccidioidomycosis

ICD-10 Code B38.3 is critical for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure accurate documentation of symptoms and treatment plans.
• Use B38.3 in conjunction with relevant clinical findings for claims.
• Include patient history of exposure to endemic areas in documentation.

Common CPT Pairings: